LakeShore Biopharma Co Operating Income

Latest operating income for YS: $-450M.

Get informed when a big investor buys or sells

+ Follow

Quarterly Operating Income

$-181145517.00

As of Mar 31, 2024

Annual Operating Income (TTM)

$-446070517.00

Trailing 12 months ending Mar 31, 2024

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin

LakeShore Biopharma Co (YS) FAQ

LakeShore Biopharma Co (YS) currently reports a operating income of $-450M as of March 2024. Use the charts on this page to explore LakeShore Biopharma Co's operating income history and peer comparisons.

LakeShore Biopharma Co reported $-450M in operating income as of March 2024. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-450M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for LakeShore Biopharma Co, and consider following YS for alerts when major investors trade the stock.